Skip to main content
. 2025 Dec 8;32:24. doi: 10.1186/s10020-025-01405-0

Table 2.

Overview of RGC differentiation protocols from hPSCs published in the past five years (2020–2025)

Cell type Culture format Isolation/enrichment Method Percentage of RGCs Total protocol length References

hiPSC

• keratinocytes or blood cells- derived

2D adherent culture None

Flow:

• 87% POU4F+

• 93% SNCG+

• 22.5% RBPMS+

• 85.5% CD90/THY1+

36 days [47]

hiPSC:

• CHOPWT8

• CHOPWT9

• CHOPWT10

2D adherent culture MACS using Thy1.2 microbeads

Flow (before MACS):

• 58% THY1+

• 84% POU4F2+

• 12% RBPMS+

Immunocytochemistry:

• 95% POU4F1+ (with MACS)

35 days [42]
hiPSC 2D adherent culture None

Varies between hiPSC-derived RGCs from different patients

Flow:

• 49.5–87% POU4F+

• 6–93% SNCG+

• 2.3–46% RBPMS+

• 42–91%CD90/THY1+

36 days [60]

hiPSC

• SIX6 risk allele

• Healthy control

2D adherent culture of neural rosettes to RGCs None

scRNA seq:

• 11.6% mature RGC (58% on retinal lineage; 20% of those in mature RGC stage)

39 days [29]

hiPSC

• MT-ND4 mutation

• Healthy control

3D embryoid bodies and neurospheres

+ 2D adherent culture of plated neurospheres

None Not stated 27 days for embryoid bodies, neurosphere generation + 18 days for neurosphere plating to neurite outgrowth [98]

hiPSC

• healthy control; fibroblast- and Müller glia-derived

3D retinal organoids + 2D adherent culture of dissociated, enriched cells

• Dissociation of retinal organoids

• MACS using human THY1 antibody

Flow:

• 60% THY1⁺ cells before sorting (dissociated culture)

• 78% THY1⁺ with MACS enrichment

56 days for retinal organoid generation + 7 days for RGC adherent culture [43]

hESC:

• H1

3D retinal organoids + 2D adherent culture of dissociated cells Dissociation of retinal organoids

Immunocytochemistry:

• 50% ATOH7+

• 30% SNCG+

• 30% ISL1+

• 50% HuC/D+

28 days for retinal organoid generation + 10 days for RGC adherent culture [24]

hiPSC

• TLHD2

• 201B7

3D retinal organoids + 2D adherent culture of dissociated, enriched cells

• Dissociation of retinal organoids

• Two-step immunopanning

Not stated

55–65 days for retinal organoid generation

+ 3–5 days for RGC adherent culture

[93]

hiPSCs

• corneal keratocytes-derived

3D retinal organoids + 2D adherent culture of dissociated cells Dissociation of retinal organoids Not stated 30 days for retinal organoid generation [97]

hPSC:

• OPTN(E50K) mutation

3D retinal organoids + 2D adherent culture of dissociated, enriched cells

• Dissociation of retinal organoids

• MACS using Thy1.2

Immunocytochemistry:

• 20–35% POU4F+

• 15–30% ISL1+

45 days for retinal organoid generation + up to 28 days for RGC adherent culture [99]

hiPSC:

• fibroblast-derived

3D retinal organoids + 2D adherent culture of retinal organoids • None

scRNA-seq:

17% RGCs (based on the expression of POU4F2, ISL1, RBPMS, SNCG, GAP43, NEFL/M, ELAVL4, EOMES, and DCX)

35 days for retinal organoid generation + 14 days for retinal organoid adherent culture [70]

hiPSC

• MT-ND4 mutation

• Healthy control

3D retinal organoids + 2D adherent culture of retinal organoids • None Not stated 35 days for retinal organoid generation + 17 days for retinal organoid adherent culture [100]

hiPSC:

• IMR90.4

• GM23720

hESC

• WA09

2D adherent culture

Genome-integrated transcription factors: NGN2, ATOH7, ISL1, POU4F2

• Clonal selection with zeocin

Immunocytochemistry:

88–94% POU4F2+ (tdTomato+)

6–7 days [86]

hiPSC:

• 297-1

hESC:

• POU4F2-driven mCherry H7-A81

2D adherent culture

Lentiviral delivery of transcription factors: NGN2

• Selection with puromycin

Immunocytochemistry:

14–20% POU4F1+

7 days [84]

hiPSC:

• NTUH-iPSC-02-02

• NTUH-iPSC-01–05

2D adherent culture

Lentiviral delivery of transcription factors: ATOH7, POU4F2, and SOX4

• Selection with puromycin + zeocin

Immunocytochemistry:

• 89.5% POU4F1+

• 94.1% ISL1+

85.3% POU4F1+/ISL1+

15–20 days [85]